Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Bethlehem W. Yacob"'
Autor:
Julie Lang, Alexis D. Leal, Juan A. Marín-Jiménez, Sarah J. Hartman, Jeremy Shulman, Natalie M. Navarro, Matthew S. Lewis, Anna Capasso, Stacey M. Bagby, Bethlehem W. Yacob, Morgan MacBeth, Brian M. Freed, S. Gail Eckhardt, Kimberly Jordan, Patrick J. Blatchford, Roberta Pelanda, Christopher H. Lieu, Wells A. Messersmith, Todd M. Pitts
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Immune checkpoint inhibitors have been found to be effective in metastatic MSI-high colorectal cancers (CRC), however, have no efficacy in microsatellite stable (MSS) cancers, which comprise the majority of mCRC cases. Cabozantinib is a small molecul
Externí odkaz:
https://doaj.org/article/4e169c4be6074370bda2cb5901dfda6f
Autor:
Sarah J. Hartmann, Juan A Marín-Jiménez, Stacey M. Bagby, Patrick J. Blanchford, Wells A. Messersmith, Bethlehem W. Yacob, Todd M. Pitts, Christopher H. Lieu, Anna Capasso, Jeremy Shulman, Julie E. Lang, Alexis D. Leal
Publikováno v:
Cancer Immunology Research. 8:A109-A109
The success of single-agent checkpoint inhibitors has been unfortunately limited to a subset of cancers. For colorectal (CRC) cancers, anti-PD1 therapies have proven to be successful in the clinic for microsatellite instable (MSI-high) tumors but hav